Skip to content

Anthralin

Published: July 26, 2026Updated: August 20, 2026

Anthralin (dithranol) is a topical antipsoriatic medication primarily used to treat chronic plaque psoriasis. It works by slowing down the excessive growth of skin cells and reducing inflammation, helping to normalize skin turnover. This medication is typically applied directly to affected skin areas and is often used as a second-line treatment when other therapies have not been effective.

Quick summary

Anthralin is a topical psoriasis treatment that slows skin cell growth and reduces inflammation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ATC
D05AC01
RxNorm
873
Generic
Anthralin
Class
atc-d05
Brands
Zithranol, Micanol, Drithocreme
Availability
rx
Lactation
unknown
Routes
topical
Forms
ointment, cream, gel
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single oral dose that may cause toxicity in adults; topical overdose less common due to route of administration
Chronic overdose: Prolonged excessive topical use may lead to local skin irritation and potential systemic absorption
Immediate actions
Gastric lavage if ingested within 1 hour, symptomatic and supportive care, discontinue topical application
Antidote
No specific antidote exists(Supportive care is primary treatment; no specific antidote available)
Poison Control: 1-800-222-1222

Special Populations

8 groups
⚠

pregnancy

first trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

topical anthralin should be used during pregnancy only if clearly needed; minimize application area and duration

Monitor

regular prenatal monitoring

Use with caution and monitor for adverse effects.

⚠

pregnancy

second trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

use only if benefits outweigh risks; limit to smallest effective area

Monitor

routine prenatal care

Use with caution and monitor for adverse effects.

⚠

pregnancy

third trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

use minimal amounts and avoid large body surface area application

Monitor

routine prenatal care

Use with caution and monitor for adverse effects.

⚠

lactation

breastfeeding
caution
FDA Category
C
Dose Adjustment

avoid on breast area

Key Recommendations

avoid applying anthralin to breast area before nursing; wash thoroughly before breastfeeding if used on other areas

Monitor

monitor infant for skin reactions

Use with caution and monitor for adverse effects.

⚠

pediatric_age

children under 12
caution
FDA Category
C
Dose Adjustment

reduce concentration and duration

Key Recommendations

use lower concentrations (0.1-0.5%); shorter application times (15-30 minutes); supervise closely

Monitor

monitor skin irritation and response

Use with caution and monitor for adverse effects.

⚠

geriatric

elderly over 65
caution
FDA Category
C
Dose Adjustment

start with lower concentrations

Key Recommendations

use lower concentrations initially; monitor for skin thinning and irritation; may have increased percutaneous absorption due to age-related skin changes

Monitor

regular skin assessment for irritation or atrophy

Use with caution and monitor for adverse effects.

✓

renal_impairment

mild to moderate
safe
FDA Category
N
Dose Adjustment

no adjustment typically needed

Key Recommendations

topical use with minimal systemic absorption; standard dosing acceptable

Monitor

standard monitoring

✓

hepatic_impairment

mild to moderate
safe
FDA Category
N
Dose Adjustment

no adjustment typically needed

Key Recommendations

topical use with minimal systemic absorption; standard dosing acceptable

Monitor

standard monitoring

Statistics and clinical data

prescribingFDA
2023

Commonly prescribed since

Value:1980s

General prescribing information for Anthralin topical treatment

drug_classWHO
2023

Drug class

Value:Topical antipsoriatic

Drug class classification for Anthralin

usageMedical guidelines
2023

Common uses

Value:Treatment of psoriasis

Primary therapeutic indication for Anthralin

mechanismFDA
2023

Mechanism of action

Value:Reduces inflammation and slows keratinocyte proliferation

Pharmacological mechanism of Anthralin

Anthralin is primarily used to treat chronic plaque psoriasis, including scalp psoriasis. It may also be used for other conditions as determined by a healthcare provider.

Anthralin works by reducing excessive skin cell proliferation (hyperproliferation) and has anti-inflammatory properties. It normalizes keratinocyte differentiation and suppresses the inflammatory responses that contribute to psoriatic lesions.

Anthralin should only be applied to affected skin areas, avoiding contact with healthy skin, face, and mucous membranes. It may cause skin irritation, staining of skin and fabrics, and should be used with caution in patients with sensitive skin. Pregnant or nursing women should consult their healthcare provider before use.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy